Check out your Company Bowl for anonymous work chats.
We are proud to announce a $14.7M grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to generate one of the world's largest, high-dimensional molecular datasets of Parkinson's patients. This data will be publicly available through Verily Workbench, empowering researchers globally to accelerate the development of new treatments and cures. “Scientific understanding of Parkinson’s disease has advanced significantly over the past decade, and we continue to seek new answers on its genetic, immunological, and molecular determinants,” said Mark Frasier, PhD, Chief Scientist at MJFF.
Dr. Sarah Thompson is helping pave the way for more individuals with chronic conditions to have access to the right care and support through her work as a Verily clinical expert, healthcare innovator and leader. Read about Sarah's personal story and the experiences that shaped her passion to build effective, safe care programs enabled by Verily technology.
Hundreds of pages of protocols, 20+ systems… clinical trials are complex. But what if they didn't have to be? Stay tuned for a new Verily N of 1 episode about how Verily is using AI to translate PDF protocols into digital models, partnering with the American Oncology Network to reimagine clinical research. 📷 Behind the scenes with Taylor Stutzman, Research Manager
There are two sessions you won’t want to miss at NACCHO Preparedness Summit 2025 on April 30 in San Antonio, TX! Both feature our Public Health Partnerships Lead Amy Lockwood. ✅ Wastewater Monitoring: An Innovative Tool for Preparing for Large-Scale Events at 8:00 AM ✅ Monitoring and Mitigating the Spread of Vector-Borne Diseases at 4:30 PM
Balancing your population’s health and cost of care with metabolic conditions is a challenge, especially due to costly GLP-1 medications. Find out how Verily’s personalized, AI-powered approach to care and management will unlock GLP-1 potential for better health while managing costs. Register for the April 30th webinar featuring Verily's Sarah Thompson and David Burdick, Heidi Guetzkow of Aon, and moderator Lydia Ramsey Pflanzer of Endpoints News.
Protocol Digitization for Clinical Research Sites Move beyond manual PDF protocol management at clinical sites. Verily Viewpoint CTMS uses AI to digitize protocols, optimizing study and financial workflows to enable sites to accelerate studies, prevent errors, and achieve profitability.
The truth about how AI is really working in healthcare 👇 “You can have extraordinarily good models to solve real problems using AI, but if you don't couple those models with human-centered design and a user-friendly interface, customers are not going to believe you. They're not going to trust you,” said Michael Radwin, Verily Senior Director of AI & Data Science at Google Cloud Next '25. During the session with Michael Ames and Mangesh Patil, they discussed AI solutions being used right now. "One product we're working on at Verily is called Lightpath, designed for people living with chronic metabolic disorders such as diabetes, obesity and cardiovascular disease. Having an AI-based coach that is empathetic, available all the time and answers questions specific to the patient is key for managing conditions. And, we've found through initial internal research, that patients are willing to talk to the AI coach longer than a human provider." - Michael Radwin Learn more about Verily Lightpath.
Today, we announced the addition of NashBio, University of Oxford, National Institutes of Health Intramural Center for Alzheimer’s and Related Dementias (CARD), and Foundation for the National Institutes of Health AMP PDRD to the growing list of organizations using Verily Workbench to manage large datasets and accelerate research. “Verily is committed to helping organizations make complex biomedical data more accessible, discoverable, and easier to analyze in order to accelerate research and improve care.” - Myoung Cha, Verily Chief Product Officer
It was great to see Verily technology featured at Google Cloud Next '25 last week. Our Distinguished Engineer Stas Zvinyatskovsky presented a demo of Vida: the Verily Developer Assistant during the session “The next frontier: Unleash the power of AI-native development with GitHub." “GitHub gives Verily developers the freedom they need to innovate. It is with that reason we developed Vida to allow our developers to invoke data commands efficiently and leverage (GitHub’s) Copilot to utilize very personalized commands to enhance productivity,” said Stas.
Inadequate sleep can be linked to increased risk of cardiovascular disease, depression, and diabetes. The clinical gold-standard tool for measuring sleep, polysomnography (PSG), is costly and in limited supply. An alternative is wearable sensor-based technology. In a recent study, we evaluated the performance of sleep tracking by the Verily Numetric Watch (VNW) against PSG among different demographic subgroups. The results demonstrate the potential of VNW to effectively measure 12 standard sleep metrics in a diverse sample of participants.
